FDA Recalls Some Valsartan Medicines Due to Impurity

Three companies are recalling several drug products containing valsartan due to the presence of N-nitrosodimethylamine, which is classified as a probable human carcinogen.
News Alerts

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply